GlassScriptPhysician profile
Anas Minkara
NPI 1649769563
$12,450.44
in general payments reported to CMS, 2019-2025
11 companies · $7,061 in 2025
The $7,061 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,732 · 2024: $3,657 · 2025: $7,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,453 · Food and Beverage: $4,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,452.55 |
| Food and Beverage | $4,997.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $4,577.63 | 2024-2025 | Xlif, Reline, Tlif |
| Medtronic, INC. | $3,051.00 | 2024-2025 | Mazor X System, Anteralign Spinal System With Titan Nanolock Surface Technology, Unid_pass |
| Stryker Corporation | $2,862.44 | 2024-2025 | Aero-Ll, Everest Spinal System, Augment Injectable |
| Nuvasive, INC. | $1,269.92 | 2023 | Xlif, Tlif, Reline |
| Cerapedics INC. | $342.60 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Zimmer Biomet Holdings, INC. | $128.11 | 2025 | Affixus |
| Heron Therapeutics, INC. | $119.70 | 2023 | Zynrelef |
| Orthofix Medical, INC. | $53.22 | 2024-2025 | Physio-Stim |
| Lenoss Medical INC | $15.96 | 2025 | Osteopearl |
| Depuy Synthes Sales INC. | $15.34 | 2024 | Conduit |
| Vertex Pharmaceuticals Incorporated | $14.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anas Minkara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.